简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-11-14 14:37 Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory
2024-11-14 09:38 Novotech Releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge
2024-11-14 09:33 AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
2024-11-13 12:57 Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
2024-11-13 12:02 Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
2024-11-12 16:16 Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
2024-11-12 10:07 Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
2024-11-08 15:06 SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
2024-11-08 14:56 BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
2024-11-06 14:48 Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award
2024-11-05 16:25 Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
2024-11-04 14:18 Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation
2024-11-04 10:30 Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
2024-11-01 17:09 Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
2024-11-01 17:02 Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
2024-11-01 15:00 US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
2024-11-01 14:56 Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
2024-11-01 14:43 ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
2024-11-01 14:39 Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer
2024-10-31 14:46 Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Business Wire Weibo

Press Releases

Latest Releases